Outlook TherapeuticsOTLK
13F holders, Q1 2024 (March 31)3holders
$11.81avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Outlook Therapeutics Inc. (OTLK) in their 13F filings. The largest holders were Rosalind Advisors, Inc. ($3.7M), Cwm, LLC ($3K) and Armstrong Advisory Group, Inc. ($1K).
- Company
- Outlook Therapeutics Inc.
- CUSIP
- 69012T206
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3.7M |
| Exits | 47 | $723K |
Ownership 3 holders
| Rosalind Advisors, Inc. | 3.48% | New | 311,775 | $3.7M |
| Cwm, LLC | 0.00% | Reduce -95.0% | 283 | $3K |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 3,580 | $1K |
"% of holder's portfolio" is OTLK's weight in each manager's 13F, not the share of Outlook Therapeutics Inc. the manager owns.